Sapience Therapeutics
PrivateLast Round
Grant
May 4, 2023
Total Funding Raised
$66M
Company Overview
Sapience Therapeutics is a biotechnology company that develops peptide-based therapeutics targeting oncogenic and immune dysregulation to combat cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sapience Therapeutics Comparables
Compare Sapience Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Circle Pharma | 80% | |
| Peptomyc | 78% | |
| Parabilis Medicines | 76% | |
Sapience Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 4, 2023 | ||||
| Grant | Oct 4, 2022 | ||||
| Series B | May 31, 2022 | ||||
| Grant | Oct 12, 2021 | ||||
| Grant | May 18, 2021 | ||||
Private Placement | Nov 17, 2020 |
Key People
Founding team and executive leadership
Sapience Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| TaiAn Technologies Corp. | Series A |
| National Institute of Allergy and Infectious Diseases | Grant |
| NIH RADx | Grant |
| Columbia University in the City of New York | Series A |
| Eshelman Ventures | Private Placement, Series A, Series B |
| Columbia Technology Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 13, 2026
Attended the 25th Annual Needham Virtual Healthcare Conference.
- Oct 4, 2022
Received grant funding from the National Cancer Institute.
Sapience Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sapience Therapeutics's valuation, stock price, and market status.